Data / Form D filings / Genevolve Vision Diagnostics, Inc.
Genevolve Vision Diagnostics, Inc.: Form D filing
Genevolve Vision Diagnostics, Inc., a biotechnology company in Albuquerque, NM, filed a Form D with the SEC in 2010. The latest, on April 30, 2010, reports $49,000 sold of an offering with no set size to 1 investor.
Find out what Genevolve Vision Diagnostics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3167 SAN MATEO BLVD. NE #368, Albuquerque, NM, 87110
- Phone
- (505) 504-9607
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- New Mexico
- Year incorporated
- 2009
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 504(b)(1)(iii)
- SEC identifier (CIK)
- 1490020
The full lists. Form D filings in New Mexico: 56 rows, $5, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 30, 2010 | New notice | Indefinite | $49,000 | Indefinite | 1 | Mar 24, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew Paul Lemelin | Executive Officer, Director |
Every Form D from the week of Apr 26, 2010 · All recent filings in New Mexico · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Genevolve Vision Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.